Intensive Care Unit Outcomes and Mortality in Elderly Oncology Patients

Author:

TIMUROGLU ArifORCID,MUSLU SeldaORCID,DANACI AysegulORCID,CAN URESIN ErceORCID,UNVER SuheylaORCID

Abstract

Introduction: Rising life expectancy has increased elderly admissions to intensive care units. With age, comorbidity risks rise. Intensive care units’ hospital mortality for elderly patients stands at 24% to 40%. Oncology patients often require intensive care units care, stemming from cancer-related conditions, treatment complications, or other health issues. However, intensive care units’ mortality remains higher among cancer patients. Materials and Method: Ethics committee-approved retrospective analysis covered oncology patients aged 65+ in intensive care units from Jan 2020 to Dec 2021. We categorized patients into two age groups, reviewing demographic data, admissions’ reasons, cancer types, recent treatments, APACHE II and SOFA scores, ventilator use, renal replacement therapy need, intensive care units /hospital durations, mortality rates, primary diseases, and comorbidities. Results: Among 706 intensive care units’ patients, 25% were over 65 with similar mortality across age groups. Lung/colon tumors and acute leukemias were common. Hematological cancer had higher APACHE II scores but similar mortality. Vasoactive drugs and mechanical ventilation significantly affected intensive care units and hospital mortality. Mortality increased in patients without vasoactive drugs/ventilation during hospitalization. Recent surgery correlated with lower hospital mortality in cancer patients. Mechanical ventilation and vasoactive drugs doubled mortality risk. Surgical admissions showed lower mortality. Renal replacement therapy correlated with higher mortality. No significant survival difference existed between cancer types. Conclusion: In conclusion, treatments impact elderly oncology patients’ survival in intensive care units /hospitals. Intensive care units’ care’s effectiveness in older groups, especially those 75+, suggests potential benefits. Non-surgical admissions and life support contribute to higher mortality. Further studies on pre- intensive care unit treatment and admission timing are essential. Keywords: Neoplasms; Critical Care; Aged.

Publisher

Bayt Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3